The Society of Gynecologic Oncology (SGO) and The Association of Community Cancer Centers (ACCC) were awarded a joint independent medical education grant from AstraZeneca and Merck, and are working together to optimize outcomes in ovarian cancer using personalized medicine. The first two resources, a podcast on genetic testing and a webinar on PARP inhibitor sequencing, now available on SGO ConnectEd, are free and open to everyone.